Nuvectis Pharma Inc

NASDAQ:NVCT   3:59:53 PM EDT
15.66
-0.50 (-3.09%)
Earnings Announcements

Nuvectis Pharma Inc Reports First Quarter 2022 Financial Results

Published: 05/10/2022 13:04 GMT
Nuvectis Pharma Inc (NVCT) - Nuvectis Pharma, Inc. Reports First Quarter 2022 Financial Results and Business Highlights.
Nuvectis Pharma Inc Qtrly Loss per Share $0.32.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.24

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.26

More details on our Analysts Page.